Skip to content

Sam's News — health — 2026-08-03

TL;DR

M&A

Bristol Myers Squibb and AstraZeneca in reported merger discussions

AstraZeneca and Bristol Myers Squibb are reportedly in early-stage talks over a merger that would create a roughly $400 billion pharmaceutical giant, though no deal is confirmed.

  • AstraZeneca market cap ~$264 billion (£196 billion); Bristol Myers Squibb ~$133 billion
  • Combined firm would be world's fourth-largest drugmaker by market cap
  • AstraZeneca shares fell up to 7.8%; Bristol Myers Squibb shares rose up to 3.8%
  • Portfolios overlap in oncology, raising possible antitrust scrutiny
  • Neither company has confirmed talks, first reported by the Financial Times

Sources: STAT News Research, Reuters RSS, Investing.com RSS, Investopedia RSS

Sandoz to pay $478.5 million to settle price-fixing allegations

Sandoz agreed to pay $478.5 million to settle allegations of price-fixing conspiracy involving pharmaceutical pricing inflation.

Sources: STAT News RSS

Healthcare

BioNTech names Guido Oelkers as new CEO replacing cofounder Ugur Sahin

Guido Oelkers was appointed CEO of BioNTech, assuming leadership from cofounder Ugur Sahin.

Sources: STAT News RSS

Science

Aging protein may trigger neurodegeneration in brain disease

Researchers identified protein EPS8 buildup with age as a molecular switch triggering toxic protein clumping linked to ALS and Huntington's disease.

Sources: ScienceDaily RSS, ScienceDaily — Health RSS

Two new compounds reveal hidden Alzheimer's disease drivers

Vanderbilt researchers created compounds to selectively inhibit and activate TAOK proteins, offering new research tools for Alzheimer's disease investigation.

Sources: ScienceDaily RSS, ScienceDaily — Health RSS

Two poisonous flowers inspire compounds for powerful new medicines

Scientists identified six enzymes in wolfsbane and larkspur plants that create medically promising atisinium compound.

Sources: ScienceDaily RSS, ScienceDaily — Health RSS

Health

Arginine-rich diets boost immune response to cancer and viruses

Research in mice shows arginine supplementation reduces colon tumors and milder viral infections by boosting immune cellular warning proteins.

Sources: ScienceDaily RSS, ScienceDaily — Health RSS